589 related articles for article (PubMed ID: 17570206)
1. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease.
Selby W; Pavli P; Crotty B; Florin T; Radford-Smith G; Gibson P; Mitchell B; Connell W; Read R; Merrett M; Ee H; Hetzel D;
Gastroenterology; 2007 Jun; 132(7):2313-9. PubMed ID: 17570206
[TBL] [Abstract][Full Text] [Related]
2. Antimycobacterial therapy in Crohn's disease: game over?
Peyrin-Biroulet L; Neut C; Colombel JF
Gastroenterology; 2007 Jun; 132(7):2594-8. PubMed ID: 17570230
[No Abstract] [Full Text] [Related]
3. Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team.
Benson CA; Williams PL; Cohn DL; Becker S; Hojczyk P; Nevin T; Korvick JA; Heifets L; Child CC; Lederman MM; Reichman RC; Powderly WG; Notario GF; Wynne BA; Hafner R
J Infect Dis; 2000 Apr; 181(4):1289-97. PubMed ID: 10762562
[TBL] [Abstract][Full Text] [Related]
4. Anti-mycobacterial therapy in Crohn's disease heals mucosa with longitudinal scars.
Borody TJ; Bilkey S; Wettstein AR; Leis S; Pang G; Tye S
Dig Liver Dis; 2007 May; 39(5):438-44. PubMed ID: 17369114
[TBL] [Abstract][Full Text] [Related]
5. A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Research on AIDS.
Cohn DL; Fisher EJ; Peng GT; Hodges JS; Chesnut J; Child CC; Franchino B; Gibert CL; El-Sadr W; Hafner R; Korvick J; Ropka M; Heifets L; Clotfelter J; Munroe D; Horsburgh CR
Clin Infect Dis; 1999 Jul; 29(1):125-33. PubMed ID: 10433575
[TBL] [Abstract][Full Text] [Related]
6. Australian Crohn's antibiotic study opens new horizons.
Gitlin L; Biesecker J
Gastroenterology; 2007 Nov; 133(5):1743-4; author reply 1745-6. PubMed ID: 17983826
[No Abstract] [Full Text] [Related]
7. The Australian antibiotic trial in Crohn's disease: alternative conclusions from the same study.
Kuenstner JT
Gastroenterology; 2007 Nov; 133(5):1742-3; author reply 1745-6. PubMed ID: 17983824
[No Abstract] [Full Text] [Related]
8. Importance of the Australian Crohn's disease antibiotic study.
Chamberlin W
Gastroenterology; 2007 Nov; 133(5):1744-5; author reply 1745-6. PubMed ID: 17983827
[No Abstract] [Full Text] [Related]
9. Antimycobacterial therapy in Crohn's disease: results of a controlled, double-blind trial with a multiple antibiotic regimen.
Prantera C; Kohn A; Mangiarotti R; Andreoli A; Luzi C
Am J Gastroenterol; 1994 Apr; 89(4):513-8. PubMed ID: 8147352
[TBL] [Abstract][Full Text] [Related]
10. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
Shafran SD; Singer J; Zarowny DP; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG; Fanning MM; Tsoukas CM
N Engl J Med; 1996 Aug; 335(6):377-83. PubMed ID: 8676931
[TBL] [Abstract][Full Text] [Related]
11. Open clinical trial of rifabutin and clarithromycin therapy in Crohn's disease.
Shafran I; Kugler L; El-Zaatari FA; Naser SA; Sandoval J
Dig Liver Dis; 2002 Jan; 34(1):22-8. PubMed ID: 11930899
[TBL] [Abstract][Full Text] [Related]
12. Treatment of severe Crohn's disease using antimycobacterial triple therapy--approaching a cure?
Borody TJ; Leis S; Warren EF; Surace R
Dig Liver Dis; 2002 Jan; 34(1):29-38. PubMed ID: 11926571
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial treatment with the fixed-dose antibiotic combination RHB-104 for Mycobacterium avium subspecies paratuberculosis in Crohn's disease: pharmacological and clinical implications.
Savarino E; Bertani L; Ceccarelli L; Bodini G; Zingone F; Buda A; Facchin S; Lorenzon G; Marchi S; Marabotto E; De Bortoli N; Savarino V; Costa F; Blandizzi C
Expert Opin Biol Ther; 2019 Feb; 19(2):79-88. PubMed ID: 30574820
[TBL] [Abstract][Full Text] [Related]
14. Flawed Australian CD study does not end MAP controversy.
Lipton JE; Barash DP
Gastroenterology; 2007 Nov; 133(5):1742; author reply 1745-6. PubMed ID: 17983825
[No Abstract] [Full Text] [Related]
15. Anti-tuberculous therapy for maintenance of remission in Crohn's disease.
Patton PH; Parker CE; MacDonald JK; Chande N
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD000299. PubMed ID: 27444319
[TBL] [Abstract][Full Text] [Related]
16. An antibiotic regimen for the treatment of active Crohn's disease: a randomized, controlled clinical trial of metronidazole plus ciprofloxacin.
Prantera C; Zannoni F; Scribano ML; Berto E; Andreoli A; Kohn A; Luzi C
Am J Gastroenterol; 1996 Feb; 91(2):328-32. PubMed ID: 8607501
[TBL] [Abstract][Full Text] [Related]
17. The use of antimycobacterial agents in Crohn's disease.
Thayer WR
J Clin Gastroenterol; 1992 Jul; 15(1):5-7. PubMed ID: 1323594
[TBL] [Abstract][Full Text] [Related]
18. Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial.
Targan SR; Feagan BG; Fedorak RN; Lashner BA; Panaccione R; Present DH; Spehlmann ME; Rutgeerts PJ; Tulassay Z; Volfova M; Wolf DC; Hernandez C; Bornstein J; Sandborn WJ;
Gastroenterology; 2007 May; 132(5):1672-83. PubMed ID: 17484865
[TBL] [Abstract][Full Text] [Related]
19. Clarithromycin with minocycline and clofazimine for Mycobacterium avium intracellulare complex lung disease in patients without the acquired immune deficiency syndrome. GETIM. Groupe d'Etude et de Traitement des Infections à Mycobactéries.
Roussel G; Igual J
Int J Tuberc Lung Dis; 1998 Jun; 2(6):462-70. PubMed ID: 9626603
[TBL] [Abstract][Full Text] [Related]
20. A comparison of budesonide with prednisolone for active Crohn's disease.
Rutgeerts P; Löfberg R; Malchow H; Lamers C; Olaison G; Jewell D; Danielsson A; Goebell H; Thomsen OO; Lorenz-Meyer H
N Engl J Med; 1994 Sep; 331(13):842-5. PubMed ID: 8078530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
